Cost-Utility Analysis of Ingenol Mebutate Versus Imiquimod...

Value in Health 2015 / 11 Vol. 18; Iss. 7

Cost-Utility Analysis of Ingenol Mebutate Versus Imiquimod 5% for Actinic Keratosis Treatment In Spain

Ortega-Joaquin, N, Elías, I, de la Cueva, P, Del Pozo, LJ, Boada, A, Moreno, D, Aguilar, M, Mosquera, E, Mirada, A, Gibbons, C, Oyagüez, I
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.569
Date:
November, 2015
File:
PDF, 53 KB
english, 2015
Conversion to is in progress
Conversion to is failed